These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21150593)

  • 1. Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections.
    Lawn SD; Török ME; Wood R
    Curr Opin Infect Dis; 2011 Feb; 24(1):34-42. PubMed ID: 21150593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
    Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
    Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
    Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
    Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
    AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
    Deconinck L; Yazdanpanah Y; Gilson RJ; Melliez H; Viget N; Joly V; Sabin CA
    HIV Med; 2015 Apr; 16(4):219-29. PubMed ID: 25522796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
    Török ME; Yen NT; Chau TT; Mai NT; Phu NH; Mai PP; Dung NT; Chau NV; Bang ND; Tien NA; Minh NH; Hien NQ; Thai PV; Dong DT; Anh DT; Thoa NT; Hai NN; Lan NN; Lan NT; Quy HT; Dung NH; Hien TT; Chinh NT; Simmons CP; de Jong M; Wolbers M; Farrar JJ
    Clin Infect Dis; 2011 Jun; 52(11):1374-83. PubMed ID: 21596680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of immunological failure and determinants of suboptimal CD4 testing among adults with HIV on first-line antiretroviral therapy in Andhra Pradesh, India, 2008-2011.
    Allam RR; Murhekar MV; Bhatnagar T; Uthappa CK; Nalini C; Rewari BB; Mehendale SM
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):325-33. PubMed ID: 25778736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Causes of death in patients with HIV infection in two Tunisian medical centers].
    Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A
    Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to start antiretroviral therapy during tuberculosis treatment?
    Naidoo K; Baxter C; Abdool Karim SS
    Curr Opin Infect Dis; 2013 Feb; 26(1):35-42. PubMed ID: 23188213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
    Lawn SD; Harries AD; Wood R
    Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.
    Lawn SD; Campbell L; Kaplan R; Little F; Morrow C; Wood R;
    BMC Infect Dis; 2011 Sep; 11():258. PubMed ID: 21957868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
    Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y
    Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
    Kerkhoff AD; Wood R; Lawn SD
    AIDS; 2011 Apr; 25(7):1003-6. PubMed ID: 21346513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India.
    Sharma SK; Kadhiravan T; Banga A; Goyal T; Bhatia I; Saha PK
    BMC Infect Dis; 2004 Nov; 4():52. PubMed ID: 15555069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
    Fox MP; Sanne IM; Conradie F; Zeinecker J; Orrell C; Ive P; Rassool M; Dehlinger M; van der Horst C; McIntyre J; Wood R
    AIDS; 2010 Aug; 24(13):2041-50. PubMed ID: 20613459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta-analysis.
    Burke RM; Rickman HM; Singh V; Corbett EL; Ayles H; Jahn A; Hosseinipour MC; Wilkinson RJ; MacPherson P
    J Int AIDS Soc; 2021 Jul; 24(7):e25772. PubMed ID: 34289243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.